Medical Device Registration in Indonesia: A Practical Guide for Foreign Manufacturers

Medical device registration in Indonesia is rarely "just paperwork" for foreign manufacturers. Early regulatory choices can lock in, or limit, how easily you manage the product over time, from approval speed to post-approval changes. In a market as large as Indonesia, those early choices carry real commercial weight.

That is why the most efficient registrations usually begin by locking in 3 fundamentals:

• License holder strategy: who holds the license, and whether that structure stays stable if distributors change
• Classification strategy: how the device is classified, since classification drives evidence expectations and review depth
• Dossier strategy: how the dossier is built, so the submission is complete, consistent, and easy to evaluate

Continue reading for the full guide to medical device registration in Indonesia. Or contact Cisema for support with Indonesian medical device registration, consulting and Authorized Representative services.

Indonesia's Medical Device Market Opportunity

Before delving into the registration steps, it helps to briefly frame why Indonesia is attracting so much attention from overseas manufacturers. The short version is that demand is growing, funding is flowing into system upgrades, and imported technology still plays a major role in supplying higher-end needs.

According to the U.S. government's Country Commercial Guide, Indonesia's medical device market was expected to reach USD 2.78 billion in 2025, with ongoing reliance on imported advanced equipment.

Several drivers sit behind that growth:

• Healthcare investment and infrastructure upgrades, including a planned IDR 218.5 trillion health allocation in 2025
• Near-universal payer coverage, with JKN covering over 278 million people and approaching 99% population coverage
• Modernization-focused procurement programs, including the SIHREN, SOPHI, and InPULS initiatives totaling roughly USD 4 billion (MoH vendor conference materials)

On the supply side, AHK/EKONID notes that Indonesia's largest medical device import sources include China, Germany, and the United States, reinforcing that international manufacturers remain central to meeting demand.

Indonesia Medical Device Regulatory Framework

With the market context in place, the regulatory structure is straightforward. Indonesia's medical device framework is set under Ministry of Health Regulation No. 62 of 2017 on product licenses for medical devices, IVDs, and household health products, and it is administered by Indonesia's Ministry of Health (MoH).

For foreign manufacturers, the key execution point is legal responsibility. All medical devices and IVDs must be registered with the MoH before importation, distribution, or sale, and overseas companies cannot submit directly. A locally established Indonesian legal entity must interface with the authority and carry regulatory accountability.

Two structural rules shape the process from start to finish:

• Regulatory accountability must sit within Indonesia
• Medical device registration is tied to the manufacturing site

That second rule is often the first real planning checkpoint for global companies. If the same product family is made at multiple manufacturing sites, Indonesia will typically treat these as separate registrations, which affects workload, timelines, and long-term maintenance.

With this model clear, the next operational question is unavoidable: who will represent you locally and hold the registration?

Authorized Representative Requirements for Medical Device Registration in Indonesia

For foreign manufacturers, an Indonesian Authorized Representative (AR) is far more than a local contact. The AR is the legal entity that holds the Registration Certificate (NIE) and serves as the formal interface with the MoH. As a result, the AR model you choose influences both approval speed and long-term commercial flexibility.

The AR's responsibilities extend well beyond initial submission:

• Holding the Registration Certificate (NIE)
• Preparing and submitting dossiers via the MoH Regalkes system
• Managing official correspondence and responses to MoH queries
• Overseeing post-market surveillance, complaints, and recalls
• Managing renewals, variations, and administrative updates

Many overseas manufacturers initially appoint a distributor as AR because it appears convenient. The downside often emerges later, when commercial strategy changes and the registration is effectively locked to a partner relationship. This is why it is usually best to confirm classification and pathway first, then structure license ownership to support long-term control.

Medical Device Classification in Indonesia and Regulatory Pathways

Classification is where strategy meets regulatory reality. In Indonesia, the risk class determines how deeply the Ministry of Health (MoH) will review your application, what supporting evidence must be ready, and how quickly the review can be completed. A well-supported classification keeps the dossier moving. A questionable one often leads to queries, rework, and delay.

The table below summarizes Indonesia's risk classes, typical example devices, and whether test report evidence is generally expected before submission:

For most devices, test report evidence, such as relevant safety, performance, or standards-based testing, should be ready before submission.

Step-by-Step: Medical Device Registration in Indonesia

With classification and evidence expectations confirmed, registration can be managed as a defined workflow. For foreign manufacturers, medical device registration in Indonesia is easiest to manage when the objective stays clear: submit a complete, internally consistent dossier through the Ministry of Health (MoH) system, reduce follow-up questions, and secure an NIE (Nomor Izin Edar) that supports stable importation and distribution.

Most Indonesia medical device registrations follow the same workflow, with the depth of evidence and review time varying by device class:

In practice, this also means confirming early whether Indonesia's halal requirements apply, as devices containing animal-derived materials or involving direct body contact may require additional documentation or labeling (see Indonesia's Halal Requirements for Medical Devices).

Two execution points consistently reduce delays:

• Dossier consistency matters as much as dossier completeness. Small mismatches between labeling, intended use, and technical description can trigger avoidable questions.
• Grouping decisions can reduce workload when applied carefully. Well-justified Family or System submissions often reduce workload compared to fragmented single-item filings.

The NIE is typically valid for up to 5 years, but it can be limited by the Letter of Authorization (LoA). Tracking both prevents renewals from becoming a hidden bottleneck.

Typical Timelines for Medical Device Registration in Indonesia

Timelines are usually predictable when the dossier is clear and evidence matches the device class. The biggest swing factor is the number and complexity of MoH clarification rounds.

Indonesia Medical Device Registration, Renewal, and Modification Fees

Fees are standardized, but total cost is heavily influenced by classification, grouping strategy, and how often you expect changes.

Tips for Overseas Medical Device Manufacturers Entering Indonesia

Once the process is understood, performance usually improves through a few structural decisions that protect control, reduce repeat work, and keep compliance stable as commercial plans change.

Tip 1: Keep Control of Registrations by Using an Independent License Holder

If you treat the AR decision as "just a submission requirement," you may end up locking your regulatory assets to a distributor relationship. Many manufacturers avoid this by appointing an independent license holder who is not tied to product sales.

This structure is especially useful when you expect to expand beyond a single distributor or want to preserve negotiating leverage while staying compliant. Cisema supports this model through its local entity in Jakarta, acting as an independent license holder when appropriate.

Tip 2: Treat Classification and Grouping as a Portfolio Strategy

Classification drives evidence expectations, review intensity, and cost. Grouping determines how many applications you file and how efficiently you can maintain them.

Before drafting the dossier, confirm:

• Device class based on intended use, user profile, and risk
• Grouping approach (Single, Family, System, IVD Set) aligned to MoH practice
• Inclusion of technically connected accessories where permitted

Tip 3: Plan Registrations Around Manufacturing Sites from Day 1

Because Indonesia links registration to the manufacturing site, multi-site portfolios or planned production transfers often trigger additional regulatory work.

To reduce disruption:

• Map all manufacturing sites tied to the portfolio
• Align the registration plan with production and transfer timelines
• Avoid late-stage site changes that trigger new licenses or variations

Tip 4: Build a "Query-Ready" Dossier to Keep Reviews Moving

Many delays come from inconsistencies, not missing documents. A "query-ready" dossier typically has:

• Consistent intended use across CSDT sections, labeling, and IFU
• Clear device description and configuration boundaries
• Traceable evidence that matches the stated class and claims

This also includes anticipating country-specific requirements, such as halal documentation where applicable.

Tip 5: Align Launch Expectations with Regulatory Reality

Launch dates are easier to protect when commercial planning reflects regulatory reality. In practice:

• Align product launch plans with class-based timeline ranges
• Build buffer time for questions and clarifications
• Avoid committing to distribution timelines before NIE issuance

Final Thoughts: Achieving Successful Medical Device Registration in Indonesia

Medical device registration in Indonesia is structured, risk-based, and achievable for overseas manufacturers that plan carefully. By selecting the right local AR model, confirming classification and grouping upfront, and submitting a consistent CSDT, overseas companies can reduce review cycles and reach approval efficiently for many portfolios.

For manufacturers building a long-term presence in Indonesia and Southeast Asia, working with an independent license holder, such as Cisema, can help maintain control of registrations, protect regulatory data, and adapt distributor strategy without unnecessary regulatory disruption. To start your medical device registration strategy in Indonesia with confidence, get in touch today.

Further Information

• Learn more about Cisema's support model in Indonesia, including regulatory strategy, dossier preparation, and Authorized Representative options: Cisema's Medical Device Registration Services in Indonesia.
• Learn more about Indonesia's halal framework for medical devices in our dedicated article: Indonesia's Halal Requirements for Medical Devices.

References

For readers who want to review the underlying market and policy context, the following sources provide helpful background:

• Indonesia's New Health Act Opens Door Further for Investors in the Medical Devices Sector (German-Indonesian Chamber of Commerce and Industry)
• Indonesia Country Commercial Guide: Healthcare and Medical Devices & Equipment (International Trade Administration, U.S. Department of Commerce)
• Ministry of Health Regulation No. 62 of 2017 on Product License of Medical Devices, In Vitro Diagnostic Medical Devices and Household Health Products (Ministry of Health of the Republic of Indonesia)

Medical Device Registration in Indonesia FAQs for Foreign Manufacturers

Can a foreign manufacturer register a medical device in Indonesia without an Authorized Representative?

No. A foreign manufacturer cannot register directly with the MoH. An Indonesian Authorized Representative is required to submit the application, hold the NIE, and manage post-market obligations in Indonesia.

How long is the Indonesian medical device Registration Certificate (NIE) valid?

The NIE is generally valid for up to 5 years. In practice, validity can be influenced by the validity period of the Letter of Authorization, so manufacturers should manage both documents together.

Do Class A Notification products require a test report in Indonesia?

Class A Notification products typically follow a simplified notification route and do not require a test report. For Class A, B, C, and D devices, a test report is generally expected before submission.

Is registration in Indonesia based on the product or the manufacturing site?

Registration is based on the manufacturing site. Each manufacturing site generally requires its own license, even if similar products are produced across multiple sites. This is important for portfolio planning and production transfers.

Can a manufacturer change distributors without re-registering the product?

It depends on who holds the registration. If the license is held by a distributor-linked AR, changing distributors can trigger re-registration or transfer complexity. If the license is held by an independent license holder, manufacturers typically have more flexibility to change or add distributors without disrupting regulatory status.